Early infancy as a critical period for development of obesity and related conditions

Matthew W Gillman1

  • 1Obesity Prevention Program, Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA.

Insights

Rapid infant weight gain in the first six months is linked to later obesity and high blood pressure. More research is needed to understand early life factors influencing infant adiposity and develop effective interventions.

Area of Science:

  • Pediatrics
  • Public Health
  • Developmental Biology

Background:

  • The global obesity epidemic impacts infants, highlighting the critical early postnatal period for energy homeostasis.
  • Animal studies and human observational data indicate rapid infant weight gain predicts future obesity and hypertension.
  • Existing research points to the first half of infancy as a key period for developing long-term health trajectories.

Purpose of the Study:

  • To address remaining questions regarding early life factors influencing infant adiposity and long-term health outcomes.
  • To identify modifiable determinants of rapid weight gain in early infancy.
  • To inform the development and implementation of cost-effective interventions for obesity prevention.

Main Methods:

  • Review of observational studies and randomized feeding trials.
  • Analysis of infant body composition data.
  • Exploration of data from developing nations to understand diverse influences on infant adiposity.

Main Results:

  • Consistent evidence links rapid infant weight gain to increased risk of later obesity and elevated blood pressure.
  • The early postnatal period is suggested as critical for establishing energy balance and preventing obesity.
  • Gaps remain in understanding body composition and data from diverse global settings.

Conclusions:

  • Early rapid infant weight gain is a significant predictor of later health issues, including obesity and hypertension.
  • Further research is essential to identify modifiable factors and develop targeted interventions for obesity prevention in infancy.
  • Integrating effective interventions into public health practices requires addressing cost-effectiveness and global applicability.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...